(Q28343091)

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314177

12 September 2022

T. Lin

series ordinal

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314177

12 September 2022

J. S. Remington

series ordinal

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314177

full work available at URL

12 September 2022

language of work or name

English

0 references

publication date

January 1992

0 references

http://link.springer.com/content/pdf/10.1007/BF01971278.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/BF01971278

http://link.springer.com/article/10.1007/BF01971278/fulltext.html

3 December 2023

1 reference

https://api.crossref.org/works/10.1007/BF01971278

http://link.springer.com/content/pdf/10.1007/BF01971278

3 December 2023

1 reference

https://api.crossref.org/works/10.1007/BF01971278

European Journal of Clinical Microbiology & Infectious Diseases

3 December 2023

published in

0 references

volume

11

0 references

issue

1

0 references

page(s)

71-3

0 references

cites work

AIDS commentary. Toxoplasmic encephalitis

1 reference

https://api.crossref.org/works/10.1007%2FBF01971278

Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971278

In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971278

In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971278

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971278

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971278

Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971278

Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity

21 January 2018

1 reference

12 December 2020

Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase

1 reference

12 December 2020

An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis

1 reference

12 December 2020

Treatment of toxoplasmic encephalitis with intravenous clindamycin

1 reference

12 December 2020

Assessment of therapy for toxoplasma encephalitis. The TE Study Group

1 reference

12 December 2020

Toxoplasmic encephalitis in patients with AIDS.

1 reference

12 December 2020

In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.

1 reference

12 December 2020

In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii

1 reference

12 December 2020

Dimensions Publication ID

Identifiers

DOI

10.1007/BF01971278

0 references

1037085506

0 references